Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17468053 | 0.93 | ALDH1A1 (0.33) | ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL1033095 | 0.84 | TSHR (0.39) | ALDH1A1TSHR | |
| SCHEMBL27796273 | 0.83 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL14350954 | 0.80 | TSHR (0.33) | ALDH1A1TSHR | |
| SCHEMBL1093563 | 0.78 | CES1 (0.31) | — | |
| SCHEMBL17464938 | 0.78 | TSHR (0.32) | TSHR | |
| SCHEMBL8111102 | 0.76 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL4712784 | 0.76 | FDPS (0.43) | ALDH1A1TSHR | |
| SCHEMBL8495787 | 0.76 | TSHR (0.30) | TSHR | |
| SCHEMBL2303938 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075427-A | Burisperidone tablet and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122070903-A | Liquid slow-release preparation | 上海建毅腾创生物医药科技有限公司 | 2026-05-22 | — | — | CN | claimed |
| CN-119971120-A | Seamable film with adhesion capability and preparation method thereof | 鹏拓生物科技(杭州)有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119770445-A | Preparation method of dapagliflozin tablet | 湖北广济药业股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-119679745-A | One-step formed enteric gelatin hollow capsule and preparation method thereof | 江苏力凡胶囊有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119607232-A | Low-adhesion sterilized gauze preparation device and preparation method | 江苏信立康医疗科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119285855-A | Copolymer electrolyte based on N-vinyl pyrrolidone and preparation method thereof | 上海宇昂水性新材料科技股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-119215020-A | The present vitamin mod oral soluble film composition, its preparation method and its application in medicine | 上海泽德曼医药科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-116251075-B | Lansoprazole enteric capsule and preparation method thereof | 江苏慧聚药业股份有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-113842376-B | Pharmaceutical composition containing risperidone, oral film and preparation method | 齐鲁制药有限公司 | 2024-10-11 | — | — | CN | claimed |
| WO-2004011054-A2 | INJECTABLE MULTIMODAL POLYMER DEPOT COMPOSITIONS AND USES THEREOF | ALZA CORPORATION (US) | 2004-02-05 | — | — | WO | claimed |
| US-20040022859-A1 | Injectable multimodal polymer depot compositions and uses thereof | DURECT CORPORATION | 2004-02-05 | — | — | US | claimed |
| US-6673767-B1 | DRUG DELIVERY USING TIME-RELEASE AGENTS COMPRISINGS POLYLACTIC ACID, PLASTICIZER SOLVENTS SELECTED FROM BENZYL OR ETHYL BENZOATE AND CDNA, DNA, PROTEINS, PEPTIDES AND/OR ANTICARCINOGENIC AGENTS | ALZA CORPORATION | 2004-01-06 | — | — | US | claimed |
| US-20030211974-A1 | Gel composition and methods | DURECT CORPORATION | 2003-11-13 | — | — | US | claimed |
| US-20030044467-A1 | Gel composition and methods | DURECT CORPORATION | 2003-03-06 | — | — | US | claimed |
| US-6468961-B1 | IMPLANTABLE COMPOSITION FOR SUSTAINED DELIVERY OF BENEFICIAL AGENT COMPRISING POLYLACTIDE POLYMER, AMOUNT OF SOLVENT COMPRISING LOWER ALKYL OR ARALKYL ESTER OF BENZOIC ACID EFFECTIVE TO FORM VISCOUS GEL, BENEFICIAL AGENT | ALZA CORPORATION | 2002-10-22 | — | — | US | claimed |
| US-6130200-A | Gel composition and methods | ALZA CORPORATION (US) | 2000-10-10 | — | — | US | claimed |
| EP-0959873-A2 | GEL COMPOSITION AND METHODS | ALZA CORPORATION (US) | 1999-12-01 | — | — | EP | claimed |
| WO-1998027963-A2 | GEL COMPOSITION AND METHODS | ALZA CORPORATION (US) | 1998-07-02 | — | — | WO | claimed |
| US-H1565-H | Superabsorbent, continuous filament web | DEUTSCHE BANK AG, NEW YORK BRANCH | 1996-07-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040022859-A1 | Injectable multimodal polymer depot compositions and uses thereof | CD44, PLOD3, PUF60 | ALDH1A1 3842/4885TSHR 1605/4885SMN1; SMN2 3165/4885 |
| US-20030211974-A1 | Gel composition and methods | CXCL8, MMP1, BMP2 | ALDH1A1 3010/4885TSHR 4201/4885SMN1; SMN2 3184/4885 |
| US-20030044467-A1 | Gel composition and methods | CXCL8, MMP1, BMP2 | ALDH1A1 3010/4885TSHR 4201/4885SMN1; SMN2 3184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.